Document Detail


The effects of nitroglycerin on regional myocardial contractile dysfunction produced by treadmill exercise or isoprenaline stimulation in dogs.
MedLine Citation:
PMID:  3146399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. To compare different methods of cardiac stress testing that are clinically applied in the management of coronary heart disease, 2 groups of dogs each were chronically instrumented and subjected to treadmill exercise or isoprenaline infusion in the presence of coronary stenosis. 2. It was of interest to determine differences in haemodynamic and regional myocardial contractile parameters, the response to antianginal therapy (nitroglycerin 15 micrograms kg-1 15 min-1, i.v.), and, in particular, whether this response differed according to the mode of cardiac stimulation, i.e. treadmill exercise or isoprenaline infusion. 3. After stenosis of the circumflex branch of the left coronary artery which affected resting myocardial function only minimally, treadmill exercise or isoprenaline infusion induced transient regional contractile dysfunction. Heart rate, arterial blood pressure, left ventricular end-diastolic pressure and left ventricular dp/dtmax were registered and myocardial oxygen demand was calculated. Regional contractile performance was assessed by ultrasonic distance measurement in the underperfused and in a normally perfused area. 4. Treadmill exercise led to an increase in systolic arterial and left ventricular end-diastolic pressure. In contrast, isoprenaline-induced stimulation led to a decrease in diastolic arterial and left ventricular end-diastolic pressure. Regional contractile function in the critically underperfused area showed a deterioration during both modes of stress. Nitroglycerin completely abolished stress-induced contractile dysfunction only in the group where treadmill exercise was employed for stimulation. 5. The inability of nitroglycerin to prevent myocardial dysfunction in the isoprenaline group may be due to exhaustion of the arterial and/or venous vasodilator potency of nitroglycerin in the presence of adrenoceptor vasodilatation induced by isoprenaline. 6. These findings indicate that clinical antianginal drug testing and the evaluation of the course of disease in patients with coronary heart disease may be highly dependent on the test method chosen.
Authors:
W Schneider; J G Grohs; G Krumpl; N Mayer; G Raberger
Related Documents :
7852519 - Effect of growth hormone (hgh) replacement therapy on physical work capacity and cardia...
2257439 - Positive inotropic effect of porcine left ventricular extract on canine ventricular mus...
17706639 - Antiarrhythmic effect of newly synthesized compound 44bu on model of aconitine-induced ...
10680659 - Comparative cardiopulmonary effects of carfentanil-xylazine and medetomidine-ketamine u...
3769589 - Favorable effects of pindolol in dilated cardiomyopathy.
2911849 - Prediction of individual dosage requirements for lignocaine: a validation study for bay...
6351119 - Electromyographic biofeedback applications to stroke patients. a critical review.
3883079 - Exercise and hypertension.
2828449 - Mechanisms of acute increases in airway responsiveness caused by environmental chemicals.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  95     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  1988 Dec 
Date Detail:
Created Date:  1989-03-17     Completed Date:  1989-03-17     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1141-50     Citation Subset:  IM    
Affiliation:
Institut für Pharmakologie, Universität Wien, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Disease / diagnosis*,  drug therapy,  physiopathology
Dogs
Exercise Test*
Hemodynamics / drug effects
Infusions, Intravenous
Isoproterenol / pharmacology
Myocardial Contraction / drug effects*
Nitroglycerin / administration & dosage,  diagnostic use*
Chemical
Reg. No./Substance:
55-63-0/Nitroglycerin; 7683-59-2/Isoproterenol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an...
Next Document:  Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase...